Cambridge Heart Antioxidant Study CHAOS

Stephens, N.G., Parsons, A., Schodiel, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J. 1996. Randomised controlled trial of vitamin E in patients with coronary disease Cambridge heart antioxidant study (CHAOS). Lancet 347, 781-786. [Pg.163]

Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, and Mitchinson MJ (1996) Randomised controlled trial ofvitaminE inpatients with coronary disease Cambridge Heart Antioxidant Study (CHAOS). Lancet 347,781-6. [Pg.453]

The ability of a-tocopherol supplementation to prevent cardiovascular events in different populations was tested in four larger prospective clinical trials The a-Tocopherol, yS-Carotene Cancer Prevention (ATBC) study, the Cambridge Heart Antioxidant Study (CHAOS), the Gruppo Italiano per lo studio della Sopravvivenza nell Infarto Miocar-dito (GISSI) trial, and the Heart Outcome Prevention Evaluation (HOPE) study. In addition, at least two smaller prospective clinical trials have been completed the Secondary Prevention with... [Pg.483]

Acronyms and abbreviations PHSl, Physician s Health Study I CHAOS, Cambridge Heart Antioxidant Study ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Stirdy NHS, Nurses Healtli Study CVD, cardiovascular disease ALS, amyotrophic lateral sclerosis NMD A, A-methyl-D-aspartate glutamate receptors. [Pg.111]

ACE, angiotensin converting enzyme ATBC, Alpha Tocopherol Beta Carotene Prevention Study CHAOS, Cambridge Heart Antioxidant Study GiSSi, GiSSI Prevenzione Triai HOPE, Heart Outcomes Prevention Evaluation Study HPS, Heart Protection Study CHD, Coronary Heart Disease CVD, cardiovascuiar disease Ml, myocardial infarction PUPA, polyunsatutated fatty acids. [Pg.34]